Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sulfonamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106866574A reveals palladium-catalyzed asymmetric reductive amination for high-purity chiral sulfonamides, offering supply chain reliability and cost efficiency.
Patent CN103228639A reveals a novel selective acyl cleavage route for Dronedarone, offering superior purity and scalable manufacturing for cardiovascular API supply chains.
Patent CN115677599A details a green synthesis route for this key veterinary API intermediate, offering higher purity and reduced environmental impact compared to traditional pyridine-based methods.
Patent CN120554257A details a novel ammoniation method enhancing purity and yield while reducing waste for reliable pharmaceutical intermediate supply chains.
Advanced purification method for Glimepiride achieving >99.9% purity. Optimized solvent systems reduce impurities and ensure scalable manufacturing for diabetes medication supply chains.
Energy-saving synthesis method for P-aminobenzene-sulfonamide using SO3 gas. Reduces waste acid and enhances supply chain reliability for pharmaceutical intermediates globally.
Patent CN113816916A details a high-yield three-step synthesis for Sulfisoxazole Sodium, offering significant cost reduction and supply chain reliability for aquaculture antibiotics.
Patent CN109678900B reveals a high-yield ionic liquid catalyzed route for phosphonate sulfonamides, offering significant cost reduction in pharmaceutical manufacturing and superior activity against MRSA.
Patent CN109134402A reveals efficient one-step synthesis technology. Offers significant cost reduction and supply reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN114920670B reveals a novel two-step synthesis for 5-chloro-2-aminobenzenesulfonamide, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Advanced synthesis of dihydrobenzofuran carboxamide derivatives via patent CN1016420B. Offers scalable routes for high-purity neuroleptic intermediates with optimized cost efficiency.
Patent CN108558713A details a rapid UV-assisted synthesis for high-purity P-aminobenzene-sulfonamide, offering significant cost and supply chain advantages.
Patent CN112479968A reveals a room-temperature hydroamination route using KI/KHSO4, offering a cost-effective alternative to transition metals for pharmaceutical intermediates.
Patent CN107602454B details a robust synthesis for potent HIV-1 protease inhibitors. Discover cost-effective manufacturing strategies and supply chain advantages.
Patent CN112209859B reveals a safer CDI-based route for Iguratimod intermediates, offering high purity and reduced operational hazards for API manufacturing.
Novel iridium-catalyzed route for amino-(N-alkyl) benzene sulfonamide offers high atom economy and green manufacturing advantages for pharmaceutical supply chains.
Novel copper-catalyzed method for six-membered ring sulfonamide compounds. High yield, mild conditions, scalable for pharmaceutical intermediate manufacturing.
Patent CN114934287B details metal-free electrooxidative route for high-purity fluoroalkyl sulfonamides ensuring green manufacturing and stable supply chain continuity.
Patent CN117024314B details a safer synthesis route for Tamsulosin intermediates, offering high purity and reduced waste for reliable supply chain integration.
Patent CN1178921C details a novel route for ethylene glycol sulfonamides, offering reduced steps and improved purity for pharmaceutical manufacturing.